glp-1 and parkinson's The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in disease: mechanisms of action GLP-1-based therapies, including GLP-1, GLP-1R

Name: glp-1 and parkinson's The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in disease: mechanisms of action GLP-1-based therapies, including GLP-1, GLP-1R
Brand: matisco.be
SKU: 29103995559
Price: 24.54 USD
Availability: InStock
Rating: 4.2259 (24 reviews)

SKU: 29103995559

4.2

USD24.54 USD52.54

Pay in 4 interest-free payments of $6.13 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

GLP 1 based therapies, including GLP 1, GLP 1R agonists and DPP 4 Download Scientific Diagram Glucagon like peptide 1 medicines in neurological and psychiatric disorders: Cell Reports Medicine triple acting glp 1 parkinson's disease agonist glp 1 gip glucagon clinical trial Current Insights, Advantages and Challenges of Triple GLP 1 GIP Are we measuring the wrong primary outcome for GLP 1 drugs for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep

Store: matisco.be · Domain: matisco.be

Description